I

Instituto De Investigaciones Clinicas Zarate | Zarate, Argentina

Research site
(Unclaimed)
Location
Florestano Andrade 332, Zarate, Buenos Aires, Argentina
Site insights

Top conditions

Cardiovascular Diseases (4 trials)

COVID-19 (3 trials)

Atherosclerosis (2 trials)

Infarction (1 trial)

Heart Diseases (1 trial)

Top treatments

PF-07321332
Ritonavir
Bococizumab
Olpasiran
Trastuzumab
Evolocumab

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

2 of 9
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke (VESALIUS-CV)

This study will assess the effect of lowering low-density lipoprotein cholesterol (LDL-C) with evolocumab on major cardiovascular events in adults wi...

Active, not recruiting
Coronary Heart Disease (CHD)
Drug: Evolocumab
Drug: Placebo

The primary objective of this study is to compare the effect of treatment with olpasiran, to placebo, on the risk for coronary heart disease death (C...

Active, not recruiting
Atherosclerotic Cardiovascular Disease
Drug: Placebo
Drug: Olpasiran

Trial sponsors

Pfizer logo

Pfizer (5 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems